Last reviewed · How we verify
NCT03527017
Cross-Sectional Survey on the Use of Tobacco Products - Germany
trial testing Survey on Use of Tobacco Products in the General Population in Tobacco Use in 6,284 participants. Terminated before completion.
24 February 2020
Quick facts
| Lead sponsor | Philip Morris Products S.A. |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 6,284 |
| Start date | 12 March 2018 |
| Primary completion | 24 February 2020 |
| Estimated completion | 24 February 2020 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Survey on Use of Tobacco Products in the General Population
- Survey on Use of Tobacco Products in IQOS Users
Conditions studied
- Tobacco Use — all drugs for Tobacco Use →
Sponsor
Philip Morris Products S.A. — full company profile →
Who can join
18 and older, any sex, with Tobacco Use. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main purpose of the research study is to estimate the prevalence of tobacco product use and describe the tobacco use patterns in adults in Germany.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03527017
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Survey on Use of Tobacco Products in the General Population
Trials testing the same drug.
- NCT03527004 — Cross-Sectional Survey on the Use of Tobacco Products - Italy · terminated
- NCT03527030 — Cross-Sectional Survey on the Use of Tobacco Products - London (UK) · terminated
Other recruiting trials for Tobacco Use
Currently open trials in the same condition.
- NCT07162935 — Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY) · NA · recruiting
- NCT07132814 — Abuse Liability for Five Modern Oral Nicotine Products · NA · recruiting
- NCT07148232 — Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness · Phase 4 · recruiting
- NCT06983678 — Neural Correlates and Behavioral Impact of Withdrawal-induced Hyperalgesia Among People Who Smoke With and Without Chron · NA · recruiting
- NCT06922617 — STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking · NA · recruiting
Other Philip Morris Products S.A. trials
Trials by the same sponsor.
- NCT07443631 — Assessment of HPHC Exposure in Smokers Switching to THS/TP18 With Different Device Variants · NA · recruiting
- NCT07459712 — Pharmacokinetics and Pharmacodynamics of THS With LEVIA Compared to THS With TEREA and to Cigarettes · NA · active not recruiting
- NCT07408180 — Exploratory Randomized, Controlled, Dose-response Study on the Impact of Nicotine From Five Variants of a Nicotine Table · NA · active not recruiting
- NCT07135648 — Nicotine Pharmacokinetics and Pharmacodynamics of Two Variants of VM 1.0 Compared to Cigarettes in Adult Current Smokers · NA · active not recruiting
- NCT06171490 — Pharmacokinetics and Comparative Bioavailability of Nicotine From Two Variants of NP2, NP2-4mg and NP2-6mg, Compared to · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03527017 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Philip Morris Products S.A.
- Last refreshed: 28 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03527017.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing